Sale!

HLA Pre-Transplant Workup Sensitized Recipient Panel 3 Test

Original price was: 9,230 د.إ.Current price is: 8,310 د.إ.

-10%

The “HLA Pre-Transplant Workup Sensitized Recipient Panel 3 Test” is a crucial diagnostic procedure performed prior to organ transplantation, specifically designed to assess the compatibility between the donor and the recipient. This test is particularly important for recipients who are considered “sensitized,” meaning they have developed antibodies that could potentially react against the donor organ, leading to transplant rejection or failure.

Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, this test involves a comprehensive analysis of the Human Leukocyte Antigen (HLA) system. HLA molecules play a critical role in the immune system’s ability to distinguish between self and non-self, which is essential in the context of organ transplantation.

The test evaluates the recipient’s immune response to potential donors, identifying the presence of specific antibodies that could target the donor HLA. This information is vital for the transplant team to select the most compatible donor, minimize the risk of organ rejection, and tailor immunosuppressive therapy more effectively.

The cost of the “HLA Pre-Transplant Workup Sensitized Recipient Panel 3 Test” at DNA Labs UAE is 8310 AED. This investment is essential for ensuring the best possible outcomes for patients undergoing organ transplantation, significantly contributing to the success rate and longevity of the transplanted organ.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 3 Test

Components:

  • Recipient: HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex
  • HLA T & B cell lymphocyte cross match vs potential donor
  • HLA Panel Reactive IgG antibodies Class I & Class II quantitative Luminex
  • Donor specific IgG antibodies Class I & II Luminex

Price: 8310.0 AED

Sample Condition:

  • RECIPIENT: 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube AND 9 mL (4 mL min.) serum from 2 SST’s AND 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube.
  • Collect specimen preferably 48 hours after dialysis.
  • Ship refrigerated. DO NOT FREEZE.
  • Doctor’s prescription on the letterhead with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.

Report Delivery: 10-12 days

Method: Complement Dependent Cytotoxicity with DTT treatment, Reverse SSOP – Luminex, Luminex X-Map technology

Test type: Transplantation

Doctor: Nephrologist

Test Department:

Pre Test Information: Collect specimen preferably 48 hours after dialysis. Doctor’s prescription on the letterhead with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.

Test Details:

The Sensitized Recipient Panel 3 (SRP3) test is a blood test used to determine the level of antibodies in a potential organ transplant recipient’s blood. This test is used to identify individuals who may have a higher risk of rejecting a transplanted organ due to pre-existing antibodies in their blood. The SRP3 test measures the level of antibodies in the recipient’s blood against a panel of donor cells. The donor cells are selected based on the frequency of their HLA (human leukocyte antigen) types in the general population. The test is typically performed on individuals who have previously received blood transfusions, multiple pregnancies, or previous organ transplants, as these experiences can lead to the development of antibodies in the blood. The results of the SRP3 test are used to determine the level of sensitization of the recipient, which can help guide the selection of a compatible donor organ for transplantation. If a potential donor organ is found to have a high level of HLA matching with the recipient’s antibodies, it may be a good match for transplantation. Overall, the SRP3 test is an important tool in the pre-transplant workup process, as it helps to identify potential barriers to successful transplantation and allows for better matching of donor organs with compatible recipients.

Test Name HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 3 Test
Components Recipient : *HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex * HLA T & B cell lymphocyte cross match vs potential donor * HLA Panel Reactive IgG antibodies Class I & Class II quantitative Luminex * Donor specific IgG antibodies Class I & II Luminex
Price 8310.0 AED
Sample Condition RECIPIENT: 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube AND 9 mL (4 mL min.) serum from 2 SST’s AND 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Collect specimen preferably 48 hours after dialysis.Ship refrigerated. DO NOT FREEZE. Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Report Delivery 10-12 days
Method Complement Dependent Cytotoxicity with DTT treatment, Reverse SSOP – Luminex, Luminex X-Map technology
Test type Transplantation
Doctor Nephrologist
Test Department:
Pre Test Information Collect specimen preferably 48 hours after dialysis.Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Test Details

The Sensitized Recipient Panel 3 (SRP3) test is a blood test used to determine the level of antibodies in a potential organ transplant recipient’s blood. This test is used to identify individuals who may have a higher risk of rejecting a transplanted organ due to pre-existing antibodies in their blood.

The SRP3 test measures the level of antibodies in the recipient’s blood against a panel of donor cells. The donor cells are selected based on the frequency of their HLA (human leukocyte antigen) types in the general population. The test is typically performed on individuals who have previously received blood transfusions, multiple pregnancies, or previous organ transplants, as these experiences can lead to the development of antibodies in the blood.

The results of the SRP3 test are used to determine the level of sensitization of the recipient, which can help guide the selection of a compatible donor organ for transplantation. If a potential donor organ is found to have a high level of HLA matching with the recipient’s antibodies, it may be a good match for transplantation.

Overall, the SRP3 test is an important tool in the pre-transplant workup process, as it helps to identify potential barriers to successful transplantation and allows for better matching of donor organs with compatible recipients.